A retrospective study of dose-dense adjuvant paclitaxel without G-CSF support in patients with breast cancer.

被引：0
|
作者：
Singh, Anurag Kumar
Malhotra, Akshiv
Lemke, Sheila M.
机构：
[1] SUNY Upstate Med Univ, Dept Hematol Oncol, Syracuse, NY 13210 USA
[2] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[3] SUNY Upstate Med Univ, Dept Hematol & Oncol, Syracuse, NY 13210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20547
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer
    R I Lalisang
    E E Voest
    J A Wils
    J W Nortier
    F L Erdkamp
    H F Hillen
    J Wals
    H C Schouten
    G H Blijham
    British Journal of Cancer, 2000, 82 : 1914 - 1919
  • [2] Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer
    Lalisang, RI
    Voest, EE
    Wils, JA
    Nortier, JW
    Erdkamp, FL
    Hillen, HF
    Wals, J
    Schouten, HC
    Blijham, GH
    BRITISH JOURNAL OF CANCER, 2000, 82 (12) : 1914 - 1919
  • [3] Reduced G-CSF administration without toxicity in dose-dense adjuvant chemotherapy in high-risk breast cancer
    Zampa, Germano
    Scoppola, Andrea
    Moscato, Michele
    ANNALS OF ONCOLOGY, 2006, 17 : 111 - 111
  • [4] Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
    R. I. Lalisang
    F. L. G. Erdkamp
    C. J. Rodenburg
    C. T. A. M. Knibbeler-van Rossum
    J. W. R. Nortier
    A. van Bochove
    P. H. Th. J. Slee
    E. E. Voest
    J. A. Wils
    J. Wals
    O. J. L. Loosveld
    A. E. M. Smals
    G. H. Blijham
    V. C. G. Tjan-Heijnen
    H. C. Schouten
    Breast Cancer Research and Treatment, 2011, 128 : 437 - 445
  • [5] Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
    Lalisang, R. I.
    Erdkamp, F. L. G.
    Rodenburg, C. J.
    Knibbeler-van Rossum, C. T. A. M.
    Nortier, J. W. R.
    van Bochove, A.
    Slee, P. H. Th. J.
    Voest, E. E.
    Wils, J. A.
    Wals, J.
    Loosveld, O. J. L.
    Smals, A. E. M.
    Blijham, G. H.
    Tjan-Heijnen, V. C. G.
    Schouten, H. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 437 - 445
  • [6] A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
    Sugarman, Steven
    Wasserheit, Carolyn
    Hodgman, Elizabeth
    Coglianese, Maryellen
    D'Alassandro, Anne
    Fournier, Monica
    Troso-Sandoval, Tiffany
    D'Andrea, Gabriella
    Drullinsky, Pamela
    Lake, Diana
    George, Roshini
    Mills, Nancy
    Moynahan, Maryellen
    Smith, Joyce
    Panageas, Katherine
    Norton, Larry
    Hudis, Clifford
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (03) : 609 - 612
  • [7] A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
    Steven Sugarman
    Carolyn Wasserheit
    Elizabeth Hodgman
    Maryellen Coglianese
    Anne D’Alassandro
    Monica Fournier
    Tiffany Troso-Sandoval
    Gabriella D’Andrea
    Pamela Drullinsky
    Diana Lake
    Roshini George
    Nancy Mills
    Maryellen Moynahan
    Joyce Smith
    Katherine Panageas
    Larry Norton
    Clifford Hudis
    Breast Cancer Research and Treatment, 2009, 115
  • [8] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Garcia-Mata, Jesus
    Garcia-Palomo, Andres
    Calvo, Lourdes
    Mel, Ramon
    Cruz, Juan Jesus
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (11): : 739 - 744
  • [9] Dose-dense (DD) two-weekly docetaxel/doxorubicin/cyclophosphamide (TAC) with G-CSF support compared to standard adjuvant TAC in breast cancer patients
    Latifzadeh, S. Z.
    Salimi, M.
    Naghnaeian, M.
    Entezari, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Jesús García-Mata
    Andrés García-Palomo
    Lourdes Calvo
    Ramón Mel
    Juan Jesús Cruz
    Manuel Ramos
    Clinical and Translational Oncology, 2008, 10 : 739 - 744
12345